SS
Insider
Stan Smith
DirectorStan Smith (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in MAIA Biotechnology, Inc. (MAIA). Across 1 priced purchase filing, the average 21-session return was +3.6% from execution and +2.1% from disclosure (delay-adjusted; derived). The largest single filing was $100K of MAIA (75,000 sh × $1.34, as filed), executed Jun 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+3.6%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+2.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$100K
shares × price, as filed
Last traded
Jun 1
Filed Jun 2
Median ADV $915K across their filed names
Open performance→Volume by month
Buys $351K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MAIARecent filings
MAIAPURCHASE
MAIA Biotechnology, Inc.
View filing →
$100K75,000 sh × $1.34
Exec Jun 1
Filed Jun 2 · 9:01 AM ET MAIAPURCHASE MAIA Biotechnology, Inc. View filing → $251K
100,000 sh × $2.51
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET